中国动脉粥样硬化网 >> 网站地图 >> 第91页:
http://www.sinoas.com/SiteMap/Article001.htm
药物使心搏骤停的风险降低21%Drug Reduces Cardiac Arrest by 21 Percent
植入式心脏复律除颤器减少心搏骤停Implanted Defibrillators Cut Down on Cardiac Arrest
培哚普利对生存的有益作用可被对内皮的作用加强Perindopril Survival Benefit May Be Enhanced by Effect on Endothelium
40岁以上的老年人中1/4将发展为房颤One Quarter of Those Older Than Age 40 Will Develop Atrial Fibrillation
血运重建后应用ACE抑制剂对低危患者有益ACE Inhibitor After Revascularization Helps Low-Risk Patients
年轻女性获益于良性的心血管相关因素Young Women Benefit From Favorable Cardiovascular Risk Profile
院外心脏骤停存活者很少有认知功能受损Little Cognitive Impairment Seen in Out-of-Hospital Cardiac Arrest Survivors
心包动脉瓣比前一代的猪瓣膜更耐用Pericardial Aortic Valves Outlast Earlier Generation Porcine Valves
新抗凝血药能够拯救生命,节约花费New Clot Preventer Saves Lives and Money
踝臂指数对于外周动脉病的诊断最有意义Ankle Brachial Index Most Helpful to Diagnose Peripheral Arterial Disease
支架可在小动脉中使用Stenting Works on Smaller Arteries
对所有的心脏病患者进行血管成形术合理吗?Is Angioplasty Right for All Heart Patients?
食用含有N-3脂肪酸的鱼类可以降低房颤的风险Fish Containing N-3 Fatty Acids Reduce Risk of Atrial Fibrillation
不是所有的ACE抑制剂对死亡率都有相同的影响Not All ACE Inhibitors Have the Same Effect on Mortality
许多心脏病患者没有得到所需的药物Many Heart Patients Fail to Get Needed Drugs
无痛性心脏病发作危险性更大Painless Heart Attacks Pose Extra Risk
冠状动脉旁路搭桥术中输血的危险性Risk Seen in Transfusions During Bypass
抗氧化补充剂不能预防心脏病的发生Antioxidant Supplements Don’t Prevent Heart Disease
利尿剂并非对所有的心力衰竭患者都合适Diuretic Not Suited for Everyone With Heart Failure
ST段抬高型心肌梗死最新治疗指南Guidelines Updated on Management of ST-Elevation Myocardial Infarction
华法林中断期间低分子量肝素的应用Low-Molecular-Weight Heparin Useful During Warfarin Interruption
左西孟坦可以改善血管成形术后顿抑心肌功能Levosimendan Improves Function of Stunned Myocardium After Angioplasty
洋参降低华法林药效Ginseng Reduces Warfarin Efficacy
被动吸烟对心脏病风险方面的影响是以往预测值的两倍Effect of Passive Smoking on Heart Risk Double Earlier Estimates
阿托伐他汀可引起血辅酶Q10水平下降Atorvastatin Reduces Blood CoQ10 Levels
致命的血液栓塞易在男性中复发Deadly Blood Clots Likelier to Recur in Men
费用增加意味着服用延长生命药物的人减少Higher Costs Mean Fewer Take Lifesaving Drugs
对于高危高胆固醇血症患者罗苏伐他汀优于阿托伐他汀Rosuvastatin Superior to Atorvastatin for High-Risk Patients High Cholesterol
“安全”的铅浓度对动脉不安全Safe Lead Levels Not Safe for Arteries
ACE抑制剂可以减少房颤的发生ACE Inhibitors Reduce Atrial Fibrillation
他汀类药物的广泛使用与脑出血风险的增加无关Widespread Statin Use Is Not Linked to Increased Risk of Cerebral Hemorrhage
女性患者死于急性主动脉剥离的危险大于男性Acute Aortic Dissection More Deadly in Women Than in Men
钙化动脉和心脏瓣膜中含有似纳米菌结构的颗粒Calcified Arteries and Cardiac Valves Contain Nanobacteria-Like Particles
事件环记录有助于房颤的诊断Event-Loop Recording Helps Diagnose Atrial Fibrillation
心脏磁共振可以发现潜在的心尖部肥厚型心肌病Cardiac Magnetic Resonance May Spot Unrecognized Apical HCM
心脏植入式设备可以挽救生命Implanted Heart Devices Save Lives
无症状的颈动脉狭窄患者可能会从颈动脉内膜剥脱术中获益Asymptomatic Patients With Carotid Stenosis May Benefit From Carotid Endarterectomy
可以预测急性冠状动脉综合征患者死亡率的可靠模型Validated Model Predicts Mortality in Patients With Acute Coronary Syndrome
搭桥是高危心脏病病人最好的治疗方法Bypass is Best for High-Risk Heart Patients
一些心脏药物的处方并不恰当Some Heart Drugs Arent Properly Prescribed
心脏病发作后行血管成形术对女性患者更有益Angioplasty for heart attack particularly helpful for women
支架相关性死亡:一项医学未知难题Stent-Related Death a Medical Mystery
降压药物对女性性功能的影响Blood pressure drugs differ in female sex effects
深静脉血栓的风险经常被忽略DVT Risks Often Ignored
氯吡格雷治疗高危患者优于阿司匹林Clopidogrel Better than Aspirin for High-Risk Patients
褪黑激素可降低夜间血压Melatonin May Lower Nocturnal Blood Pressure
伟哥(Viagra)可用于男性胸痛患者:相关研究Viagra may be okay for men with chest pain: study
诊治先天性心脏缺陷的新方法New Ways to Catch Heart Defect
清晨冠状动脉粥样斑块破裂的风险增加Plaque rupture risk increases in the morning
冠状动脉钙化指数有助于预测心血管风险Coronary Artery Calcium Scores Aid in Cardiovascular Risk Prediction
最新发现的真菌类化合物可阻止动脉硬化New Fungus Compounds Halt Hardening of Arteries
激素救治心搏骤停——血管升压素表现最佳Hormone Boosts Cardiac Arrest Survival RateVasopressin works best in those with worst chance
ORBIT研究结果令人失望:双相除颤器未显优势ORBIT: Biphasic Defibrillator Fails to Demonstrate Advantage in Out-of-Hospital Setting
一半英国心脏病患者未从他汀类药物中获益Statin Drugs Fail Half UK Heart Patients
单用依普利酮或与依那普利合用可减轻左室肥厚Eplerenone Alone Or Combined With Enalapril Effectively Reduces Left Ventricular Hypertrophy
心肌梗死后治疗:坎地沙坦疗效超越ACE抑制剂Candesartan More Effective than ACE Inhibition Postmyocardial Infarction
他汀类药物可以有效降低胆固醇,但那种药物是首选尚有争议Statins Effectively Lower Cholesterol, But Experts Debate First Choice
联合降脂治疗可能比大剂量阿托伐他汀更有效Lipid-Lowering Combination May Be More Effective Than High-Dose Atorvastatin
MRI灌注显像可以作为评价有症状女性的一种检查手段MRI Perfusion May Be Test of Choice for Evaluation of Symptomatic Women
他汀类药物没有被充分利用而且存在使用剂量不足,即使在临床研究中也存在这种问题Statins Are Underused and Underdosed, Even in Clinical Trial Population
氯吡格雷可以降低颈动脉内膜切除术后血栓形成的风险Clopidogrel May Reduce Thrombosis After Carotid Endartectomy
评估女性心源性死亡风险的最重要因素是体能Fitness Most Important Factor in Assessing Cardiac Mortality Risk in Women
溶栓药在发生中风三小时后仍有效Thrombolytics May Have Benefit Beyond 3 Hours of Stroke Onset
他汀类药物可减少心力衰竭死亡Statins Cut Deaths From Heart Failure
心脏病风险标志物的最新发现New Heart Risk Marker Found
侵入性治疗有益于老年心脏病患者Aggressive Therapy Helps Older Heart Patients
联合用药降低心脏病患者死亡风险Drug Combo Cuts Death Risk for Heart Patients
吸血蝙蝠的唾液能治疗中风Vampire Bat Saliva Holds Key to Stroke Treatment
妇女心脏病最新预防指南New Guidelines Show Women How to Avoid Heart Disease
CCB与降压联合治疗—最佳治疗方案的循证探索
全球范围急性心肌梗死危险因素的病例对照研究A Global Case-Control Study of Risk Factors for Acute Myocardial Infarction (INTERHEART)
REACT: 补救性血管成形术、保守治疗与重复溶栓治疗的比较研究REACT: Rescue Angioplasty versus Conservative Therapy or Repeat Thrombolysis
ESCAPE:肺动脉导管检查 对充血性心力衰竭的影响评估研究ESCAPE: Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness
ARTS1:动脉血运重建治疗研究(Arterial Revascularization Therapy Study )5年临床随访ARTS 1: 5-year Clinical Follow-up of the Arterial Revascularization Therapy Study
一项减少心血管疾病发病超过80%的新策略
欧辛伐他汀生存研究(4S)癌症死亡率及发病率10年随访研究Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)
ACTION试验研究结果评论集萃
效价比更高的钙离子拮抗剂:一项从氨氯地平转换为非洛地平的疗效评价试验A CCB Which is More Cost-Effective : Evaluation of a Therapeutic Conversion From Amlodipine to Felodipine
经皮冠状动脉介入治疗后氯吡格雷长期治疗: “皇帝的新装”Long-term clopidogrel therapy after percutaneous coronary intervention: the “Emperors New Clothes”
多种药物组合的超级药丸“POLYPILL”——大众健康的解决之道?Medications Combination Forms a Super “Polypill”——An Easy Way for the People to Health?
心血管事件的二级预防:抗血小板治疗药物越“先进”越完美吗?Antiplatelet Therapy for Secondary Prevention of Cardiovascular Events: More “Advanced” Drug, More Perfect?
血压降低的程度=降压药物的疗效?Antihypertensive Drugs: Is It All in the Blood Pressure-Lowering Effect?
VALUE试验——最终带来了什么“价值”?VALUE Trial: Did VALUE add value?
PROVE-IT研究——我们是否进入了强化降脂治疗的“新时代”?PROVE-IT Study: Are We Entering the New Era of Intensive Lipid Lowering Therapy?
ACE抑制剂或钙通道阻滞剂没有表现出肾脏益处No Renal Benefit from ACE Inhibitors or Calcium Channel Blockers
罗格列酮可改善餐后甘油三酯和游离脂肪酸的代谢Rosiglitazone Improves Postprandial Triglyceride and FFA Metabolism
腰围是预测胰岛素抵抗的“金标准”Waist Circumference Gold Standard For Predicting Insulin Resistance
传统的危险因素是预测肾病患者心血管死亡的最强指标Traditional Factors Strongest Predictors of Cardiovascular Death in Renal Disease
他汀治疗肾病患者安全、有效Statin Therapy Safe and Effective in Renal Patients
基因变异可影响冠脉搭桥术后的肾损害Genes Influence Kidney Health After Coronary Bypass
分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75
76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 [91] 92 93 94 95 96 97 98 99 100
101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125
126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150
151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175
176 177 178 179 180 181 182